Trial Profile
A Phase I single ascending dose (SAD) study of TUR‐006
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2018
Price :
$35
*
At a glance
- Drugs Fanotaprim (Primary)
- Indications Toxoplasmosis
- Focus Adverse reactions; First in man
- 13 Apr 2018 New trial record